ABL Bio (298380.KQ) Earnings Analysis
ABL Bio (298380.KQ) has no confirmed upcoming earnings date. Trailing P/E -206.30.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 298380.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 298380.KQ. This page updates as the calendar is published.
298380.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -260.86 KRW | n/a | n/a | n/a |
| 2026-02-13 | -524.3 KRW | n/a | n/a | n/a |
| 2025-11-10 | -394.9971 KRW | n/a | n/a | n/a |
| 2025-02-13 | -394.77845 KRW | n/a | n/a | n/a |
298380.KQ valuation and analyst view
| Trailing P/E | -206.30 |
|---|---|
| Trailing EPS | -435.64734 KRW |
| Price / book | 22.83 |
| Dividend yield | 0.00% |
| Market cap | 3885.53B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is ABL Bio (298380.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 298380.KQ. This page updates as the calendar is published.
Did 298380.KQ beat earnings last quarter?
Consensus estimate data was not available for 298380.KQ's 2026-05-11 report.
What is 298380.KQ's current P/E ratio and EPS?
298380.KQ trades at a trailing P/E of -206.30 on trailing EPS of -435.64734437217345 KRW.
What do analysts rate 298380.KQ?
298380.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.